Epilepsy Device Market to reach USD 1.18 billion by 2032, growing at a CAGR of 5.15%

The epilepsy device market has seen remarkable growth in recent years, fueled by technological advancements and a rising global awareness of epilepsy management. This growth is primarily driven by the increasing prevalence of epilepsy worldwide, including nearly 3 million U.S. adults and about 456,000 U.S. children aged 17 and younger affected by active epilepsy in 2024, according to the CDC, creating a greater need for more effective diagnostic tools and treatment options. As a result, devices such as wearable seizure monitors, neurostimulation systems, and EEG machines have gained prominence, transforming how epilepsy is both monitored and treated. These devices enable earlier detection, better management of seizures, and ultimately improved patient outcomes, all of which contribute to the market’s continued expansion.